Evidence map›Paper›PMID 39596443›Full record

ReviewInternational journal of molecular sciences2024

Proposed Mechanisms of Cell Therapy for Alzheimer's Disease.

Ekaterina Belousova, Diana Salikhova, Yaroslav Maksimov, Vladimir Nebogatikov, Anastasiya Sudina, Dmitry Goldshtein, Aleksey Ustyugov

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Stem cell therapy use in patients with dementia: a systematic review.International journal of emergency medicine · 2025
    Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ekaterina BelousovaResearch Centre for Medical Genetics, Moscow 115522, Russia.
Diana SalikhovaResearch Centre for Medical Genetics, Moscow 115522, Russia.ORCID 0000-0001-7842-7635
Yaroslav MaksimovResearch Centre for Medical Genetics, Moscow 115522, Russia.
Vladimir NebogatikovInstitute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry of the Russian Academy of Sciences, Chernogolovka 142432, Russia.ORCID 0000-0002-2454-9255
Anastasiya SudinaResearch Centre for Medical Genetics, Moscow 115522, Russia.
Dmitry GoldshteinResearch Centre for Medical Genetics, Moscow 115522, Russia.
Aleksey UstyugovInstitute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry of the Russian Academy of Sciences, Chernogolovka 142432, Russia.ORCID 0000-0003-1977-4797

Funding

Russian Science Foundation 23-15-00362
6 · The paper itself

Abstract

Alzheimer's disease is a progressive neurodegenerative disorder characterized by mitochondria dysfunction, accumulation of beta-amyloid plaques, and hyperphosphorylated tau tangles in the brain leading to memory loss and cognitive deficits. There is currently no cure for this condition, but the potential of stem cells for the therapy of neurodegenerative pathologies is actively being researched. This review discusses preclinical and clinical studies that have used mouse models and human patients to investigate the use of novel types of stem cell treatment approaches. The findings provide valuable insights into the applications of stem cell-based therapies and include the use of neural, glial, mesenchymal, embryonic, and induced pluripotent stem cells. We cover current studies on stem cell replacement therapy where cells can functionally integrate into neural networks, replace damaged neurons, and strengthen impaired synaptic circuits in the brain. We address the paracrine action of stem cells acting via secreted factors to induce neuroregeneration and modify inflammatory responses. We focus on the neuroprotective functions of exosomes as well as their neurogenic and synaptogenic effects. We look into the shuttling of mitochondria through tunneling nanotubes that enables the transfer of healthy mitochondria by restoring the normal functioning of damaged cells, improving their metabolism, and reducing the level of apoptosis.

Indexed as

Alzheimer DiseaseMitochondriaAnimalsCell- and Tissue-Based TherapyExosomesHumansStem Cell TransplantationAlzheimer’s diseaseneuroprotectionstem cellsβ-amyloid

Identifiers

PMID39596443
PMCPMC11595163

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.